Los Angeles Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Los Angeles Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-37,709	Closed	-$787K	–	1728
2021 Q1	$787K	Sell	37,709 -2,560	-6%	-$59.1K	﹤0.01%	1015
2020 Q4	$922K	Sell	40,269 -1,920	-5%	-$36.6K	﹤0.01%	975
2020 Q3	$688K	Buy	42,189 +9,934	+31%	+$180K	﹤0.01%	955
2020 Q2	$437K	Buy	+32,255	New	+$375K	﹤0.01%	1161
2019 Q2	–	Sell	-27,002	Closed	-$868K	–	1468
2019 Q1	$868K	Sell	27,002 -4,360	-14%	-$135K	﹤0.01%	902
2018 Q4	$884K	Sell	31,362 -8,610	-22%	-$252K	0.01%	778
2018 Q3	$1.15M	Buy	39,972 +12,530	+46%	+$376K	0.01%	822
2018 Q2	$1.03M	Buy	+27,442	New	+$1.08M	0.01%	888

Other funds holding XENT

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Los Angeles Capital Management's XENT Position: Q2 2021 in Review

Los Angeles Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 37,709 shares — an estimated $787K sold.

Los Angeles Capital Management first reported a position in XENT in Q2 2018 and held it in 8 quarters. The position peaked at $1.15M in Q3 2018. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

Los Angeles Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
Los Angeles Capital Management sold 37,709 Intersect ENT, Inc shares in Q2 2021, an estimated $787K.
Los Angeles Capital Management first reported a position in Intersect ENT, Inc in Q2 2018 and held it in 8 quarters.
Los Angeles Capital Management's Intersect ENT, Inc position peaked at $1.15M in Q3 2018.
107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.